CDNA (STOCKS)
CareDx, Inc.
$24.080000
+1.110000 (+4.83%)
Prev close: $22.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John W. Hanna
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,244.22M
- Employees
- 650
- P/E (TTM)
- -149.06
- P/B (TTM)
- 3.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
3
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.34 | $0.14 | +0.2038 | +149.63% |
|
Dec 2025 (Q4)
|
$0.12 | $0.24 | -0.1239 | -50.80% |
|
Sep 2025 (Q3)
|
$0.28 | $0.14 | +0.1355 | +93.77% |
|
Jun 2025 (Q2)
|
$0.10 | $0.12 | -0.0221 | -18.10% |
Financial Statements
| Revenues | $412.82M |
| Benefits Costs and Expenses | $420.83M |
| Costs And Expenses | $420.83M |
| Nonoperating Income/Loss | $8.20M |
| Operating Expenses | $429.03M |
| Research and Development | $74.32M |
| Other Operating Expenses | $354.71M |
| Operating Income/Loss | -$16.21M |
| Income/Loss From Continuing Operations After Tax | -$8.19M |
| Income/Loss From Continuing Operations Before Tax | -$8.01M |
| Income Tax Expense/Benefit | $181.00K |
| Net Income/Loss | -$8.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.16 |
| Diluted Earnings Per Share | -$0.16 |
| Basic Average Shares | 157,235,230 |
| Diluted Average Shares | 160,442,572 |
| Assets | $411.06M |
| Current Assets | $269.40M |
| Inventory | $26.40M |
| Other Current Assets | $242.99M |
| Noncurrent Assets | $141.67M |
| Fixed Assets | $33.16M |
| Intangible Assets | $32.10M |
| Other Non-current Assets | $76.41M |
| Liabilities | $97.53M |
| Current Liabilities | $79.15M |
| Accounts Payable | $9.07M |
| Wages | $20.55M |
| Other Current Liabilities | $49.54M |
| Noncurrent Liabilities | $18.37M |
| Equity | $313.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $313.54M |
| Liabilities And Equity | $411.06M |
| Net Cash Flow From Operating Activities | $72.95M |
| Net Cash Flow From Operating Activities, Continuing | $72.95M |
| Net Cash Flow From Investing Activities | $11.89M |
| Net Cash Flow From Investing Activities, Continuing | $11.89M |
| Net Cash Flow From Financing Activities | -$95.66M |
| Net Cash Flow From Financing Activities, Continuing | -$95.66M |
| Net Cash Flow | -$10.82M |
| Net Cash Flow, Continuing | -$10.82M |
| Comprehensive Income/Loss | -$8.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.38M |
| Other Comprehensive Income/Loss | $217.00K |